Evidence map›Paper›PMID 39683279›Full record

ReviewNanomaterials (Basel, Switzerland)2024

Innovative Carbonaceous Materials and Metal/Metal Oxide Nanoparticles for Electrochemical Biosensor Applications.

Keshavananda Prabhu Channabasavana Hundi Puttaningaiah

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Keshavananda Prabhu Channabasavana Hundi PuttaningaiahSchool of Chemical, Biological, and Battery Engineering, Gachon University, Gyeonggi-do, Seongnam-si 13120, Republic of Korea.ORCID 0000-0001-7276-9335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrochemical biosensors have emerged as predominant devices for sensitive, rapid, and specific sensing of biomolecules, with significant applications in clinical diagnostics, environmental observation, and food processing. The improvement of inventive materials, especially carbon-based materials, and metal/metal oxide nanoparticles (M/MONPs), has changed the impact of biosensing, improving the performance and flexibility of electrochemical biosensors. Carbon-based materials, such as graphene, carbon nanotubes, and carbon nanofibers, have excellent electrical conductivity, a high surface area, large pore size, and good biocompatibility, making them ideal electrocatalysts for biosensor applications. Furthermore, M and MONPs have highly effective synergistic, electronic, and optical properties that influence signal transduction, selectivity, and sensitivity. This study completely explored continuous progressions and upgrades in carbonaceous materials (CBN materials) and M/MONPs for electrochemical biosensor applications. It analyzed the synergistic effects of hybrid nanocomposites that combine carbon materials with metal nanoparticles (MNPs) and their part in upgrading sensor performance. The paper likewise incorporated the surface alteration procedures and integration of these materials into biosensor models. The study examined difficulties, requirements, and possibilities for executing these innovative materials in practical contexts. This overview aimed to provide specialists with insights into the most recent patterns in the materials study of electrochemical biosensors and advance further progressions in this dynamic sector.

Indexed as

carbonaceous (CBN) materialselectrochemical biosensorsmetal nanoparticles (MNPs)metal oxide nanoparticles (MONPs)nanocomposites

Identifiers

PMID39683279
PMCPMC11642939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.